Archer Investment Corporation’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.1K Buy
232
+1
+0.4% +$196 0.01% 522
2026
Q1
$45.4K Hold
231
0.01% 542
2025
Q4
$40.2K Hold
231
0.01% 504
2025
Q3
$44.1K Hold
231
0.01% 496
2025
Q2
$41.5K Hold
231
0.01% 502
2025
Q1
$39.1K Buy
231
+27
+13% +$4.43K 0.01% 492
2024
Q4
$30.8K Hold
204
0.01% 513
2024
Q3
$31.7K Hold
204
0.01% 508
2024
Q2
$27.9K Hold
204
0.01% 499
2024
Q1
$27.2K Hold
204
0.01% 491
2023
Q4
$28.1K Hold
204
0.01% 482
2023
Q3
$24.9K Hold
204
0.01% 479
2023
Q2
$28.7K Hold
204
0.01% 459
2023
Q1
$28.9K Sell
204
-720
-78% -$103K 0.01% 442
2022
Q4
$145K Hold
924
0.06% 236
2022
Q3
$113K Hold
924
0.05% 242
2022
Q2
$123K Hold
924
0.05% 242
2022
Q1
$127K Buy
924
+720
+353% +$100K 0.04% 245
2021
Q4
$35.3K Hold
204
0.01% 413
2021
Q3
$29.6K Hold
204
0.01% 422
2021
Q2
$26.9K Hold
204
0.01% 399
2021
Q1
$26.2K Hold
204
0.01% 438
2020
Q4
$24.3K Hold
204
0.01% 403
2020
Q3
$23.4K Hold
204
0.01% 347
2020
Q2
$23.2K Hold
204
0.01% 334
2020
Q1
$16K Hold
204
0.01% 374
2019
Q4
$22K Hold
204
0.01% 386
2019
Q3
$22K Hold
204
0.01% 288
2019
Q2
$21K Hold
204
0.01% 290
2019
Q1
$18K Hold
204
0.01% 300
2018
Q4
$17K Buy
+204
New +$19.1K 0.01% 286

Other funds holding DGX

Archer Investment Corporation's DGX Position: Q2 2026 in Review

Archer Investment Corporation increased its Quest Diagnostics (DGX) stake by 0.43% in Q2 2026, buying an estimated $196 and bringing the position to 232 shares worth $49.1K. The position accounts for 0.01% of the portfolio, ranked #522.

Archer Investment Corporation first reported a position in DGX in Q4 2018 and has held it in 31 quarters since. The position peaked at $145K in Q4 2022. 802 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Archer Investment Corporation held 232 shares of Quest Diagnostics worth $49.1K as of Q2 2026.
  • Archer Investment Corporation bought 1 Quest Diagnostics share in Q2 2026, an estimated $196.
  • Quest Diagnostics made up 0.01% of Archer Investment Corporation's portfolio in Q2 2026, its #522 holding.
  • Archer Investment Corporation first reported a position in Quest Diagnostics in Q4 2018 and has held it in 31 quarters since.
  • Archer Investment Corporation's Quest Diagnostics position peaked at $145K in Q4 2022.
  • 802 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.